Choose a model
Each card values Medinotec a different way, shown at our starting inputs. Pick one to see and change how it works.
Set your assumptions
Medinotec on earnings: earnings per share grow for a few years, then the stock trades at a normal price-to-earnings multiple.
Years to project
Growth of earnings per share
Earnings per share; not enough history; starts at 5%
Exit P/E
Starts at its industry's median P/E
Your desired return
Margin of safety
More
Your buy price
The expected return is measured from it; starts at today's price
How it's worked out
Today's earnings per share
Diluted EPS of $0.05 as filed, last twelve months, lowered to what operating profit after tax supports (one-off gains left out)
$0.05
Earnings in 2031
Grows 5.0% a year for 5 years
$0.06
Price in 2031
$0.06 × 20.4 P/E
$1.18
Worth today
÷ 1.10^5: your 10% a year, taken back out
$0.73
Fair value
The most you can pay and still earn 10% a year
$0.73
Buy below
Fair value minus your 25% margin of safety
$0.55
Every rule is on the methodology page.
Outcome
What your assumptions give, and the path from today's price.
Fair value
$0.73
Expected return
Set a buy price
Future price, 2031
$1.18
Buy below
$0.55
Projection
Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.
Build your own intrinsic value for Medinotec Inc. Start from three cases based on the company's own filings, then change any number to match your view.
Conservative
$1.19
Buy below $0.90 for a 25% safety margin
Your assumptions
Base
$1.89
Buy below $1.42 for a 25% safety margin
Your assumptions
Optimistic
$3.42
Buy below $2.57 for a 25% safety margin
Your assumptions
Where today's price sits
The three intrinsic values, without a price to compare them with.
Base free cash flow
$373,899.00
Trailing twelve months
Historical FCF CAGR
+214.8%
Across 5 reported periods
Market implies
–
Needs a comparable price
Terminal value share
69%
Of the base case valuation
Growth needed to justify today's price
No growth rate in the tested range reproduces today's price at these assumptions.
Curve holds terminal growth at 2.5%, years 6 to 10 at half the first-stage rate, and applies no safety margin.
Free cash flow history
The most recent period is the base every projection starts from. Compounded, that history is +214.8% a year.
Medinotec (MDNC) intrinsic value and fair value
The calculator grows one of Medinotec's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for MDNC; this is analysis, not investment advice.
Frequently asked
What is Medinotec's (MDNC) intrinsic value?+
With Intrinsiqq's starting inputs, Medinotec's fair value is about $0.73 a share, based on its earnings per share. That assumes earnings per share of $0.05 grows about 5.0% a year for 5 years, the stock then trades at 20.4 times earnings, and you want a 10.0% yearly return. On its other figures: free cash flow $0.88, revenue $4.56. Every input can be changed on the page; the result is a model, not a forecast.
What growth does the Medinotec valuation assume?+
Earnings per share grows about 5.0% a year to start, a default, because there is too little history. The exit multiple starts at its industry's median.
What is a good margin of safety for Medinotec?+
A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at $0.55. Less predictable businesses deserve a wider cushion, or a higher desired return.
SourceFair value computed from the 10-Q filed 8 Oct 2026, covering the period ending 31 Aug 2026, as reported to the SEC. Data last refreshed 9 Oct 2026. How this is calculated.
Fiscal year ends Feb.
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with MDNC
Spot a number that looks wrong? Check it in MDNC's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MDNC
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.